SCHEMBL4070182

SCHEMBL4070182

Cc1cc(F)ccc1Oc1ccc(N)cn1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.60
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
KDM4E B2RXH2 5/20 0.58
POLB P06746 2/20 0.50
ALOX5AP P20292 2/20 0.49
FEN1 P39748 2/20 0.49
OXTR P30559 2/20 0.46
ALDH1A1 P00352 1/20 0.46
BRCA1 P38398 1/20 0.46
HBB P68871 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SLC6A4 P31645 1/20 0.45
HSPB1 P04792 1/20 0.44
MAPK14 Q16539 2/20 0.44
RAB9A P51151 2/20 0.43
MAP4K4 O95819 2/20 0.42
NPBWR1 P48145 1/20 0.38
MCHR1 Q99705 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30466093 0.88 KEAP1 (0.52) KEAP1MEN1KMT2AKDM4EPOLB
SCHEMBL25272372 0.88 KEAP1 (0.52) KEAP1MEN1KMT2AKDM4EPOLB
SCHEMBL12593846 0.87 KEAP1 (0.62) KEAP1MEN1KMT2AKDM4EPOLB
SCHEMBL15921050 0.84 MEN1 (0.71) KEAP1MEN1KMT2AKDM4EPOLB
SCHEMBL4065605 0.84 KEAP1 (0.59) KEAP1MEN1KMT2AKDM4EPOLB
SCHEMBL4061973 0.82 KDM4E (0.60) KEAP1MEN1KMT2AKDM4EPOLB
SCHEMBL21186229 0.82 KMT2A (0.59) KEAP1MEN1KMT2AKDM4EPOLB
SCHEMBL16792569 0.81 MEN1 (0.71) KEAP1MEN1KMT2AKDM4EPOLB
SCHEMBL4064464 0.81 KEAP1 (0.77) KEAP1MEN1KMT2AKDM4EPOLB
SCHEMBL30466064 0.79 KMT2A (0.54) KEAP1MEN1KMT2AKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1028945-B9 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC (US) 2009-02-18 EP disclosed
EP-1028945-B1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC (US) 2007-07-11 EP disclosed
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 US disclosed
EP-1028945-A1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS Amgen Inc. (US) 2000-08-23 EP disclosed
WO-1999024404-A1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC. (US) 1999-05-20 WO disclosed